Literature DB >> 707104

Immune complexes in the sputum of patients with cystic fibrosis suffering from chronic Pseudomonas aeruginosa lung infection.

P O Schiøtz, H Nielsen, N Høiby, G Glikmann, S E Svehag.   

Abstract

12 cystic fibrosis (CF) patients chronically infected with mucoid P. aeruginosa and presenting multiple precipitins in serum against this bacterium and 12 patients without P. aeruginosa infection were examined for occurrence of soluble immune complexes in their sputum sol phase by a complement consumption assay and a solid phase rheumatoid factor binding assay. The correlation between the results obtained in the two assays was significant (r = 0.625, p less than 0.01). The patients chronically infected with P. aeruginosa showed a significantly (p less than 0.01) higher frequency of immune complex activity in their sputum sol phase, as compared to the patients without P. aeruginosa lung infection. These findings point to the possibility that chronic lung infection with mucoid P. aeruginosa in CF may be an immune complex disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 707104     DOI: 10.1111/j.1699-0463.1978.tb02555.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand C        ISSN: 0304-1328


  11 in total

Review 1.  Innate Immune Signaling Activated by MDR Bacteria in the Airway.

Authors:  Dane Parker; Danielle Ahn; Taylor Cohen; Alice Prince
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

2.  Corticosteroid treatment in cystic fibrosis.

Authors:  J F Price; P Greally
Journal:  Arch Dis Child       Date:  1993-06       Impact factor: 3.791

Review 3.  Immunological abnormalities in cystic fibrosis: chicken or egg?

Authors:  M E Hodson
Journal:  Thorax       Date:  1980-11       Impact factor: 9.139

Review 4.  Rational parameters for antibiotic therapy in patients with cystic fibrosis.

Authors:  J R Govan; C Doherty; S Glass
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

5.  The immunoglobulin G subclass composition of immune complexes in cystic fibrosis. Implications for the pathogenesis of the Pseudomonas lung lesion.

Authors:  D B Hornick; R B Fick
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

Review 6.  Cystic fibrosis: a mucosal immunodeficiency syndrome.

Authors:  Taylor Sitarik Cohen; Alice Prince
Journal:  Nat Med       Date:  2012-04-05       Impact factor: 53.440

7.  Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis.

Authors:  G Döring; N Høiby
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

8.  Detection of antibodies to Pseudomonas aeruginosa alginate extracellular polysaccharide in animals and cystic fibrosis patients by enzyme-linked immunosorbent assay.

Authors:  L E Bryan; A Kureishi; H R Rabin
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

9.  Circulating soluble immune complexes containing pseudomonas antigens in cystic fibrosis.

Authors:  R W Pitcher-Wilmott; R J Levinsky; D J Matthew
Journal:  Arch Dis Child       Date:  1982-08       Impact factor: 3.791

10.  Interleukin-1 alpha, soluble interleukin-2 receptor, and IgG concentrations in cystic fibrosis treated with prednisolone.

Authors:  P Greally; M J Hussain; D Vergani; J F Price
Journal:  Arch Dis Child       Date:  1994-07       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.